Lisa Robinson

Ms. Lisa Robinson


Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 January 2011 in Journal of Benefit-Cost Analysis
Verified
Journal Article
Closed access
PDF file
JHJames K. Hammitt
James K. Hammitt
LRLisa Robinson
Lisa Robinson
The income elasticity of the value per statistical life (VSL) is an important parameter for policy analysis. Mortality risk reductions often dominate the quantified benefits of environmental and other policies, and estimates of their value are frequently transferred across countries with significantly different income levels. U.S. regulatory agencies typically assume that a 1.0 percent change in real income over time will lead to a 0.4 to 0.6 percent change in the VSL. While elasticities within this range are supported by substantial research, they appear nonsensical if applied to populations with significantly smaller incomes. When transferring values between high and lower income countries, analysts often instead assume an elasticity of 1.0, but the resulting VSL estimates appear large in comparison to income. Elasticities greater than 1.0 are supported by research on the relationship between long-term economic growth and the VSL, by cross-country comparisons, and by new research that estimates the VSL by income quantile. Caution is needed when applying these higher elasticities, however, because the resulting VSLs appear smaller than expected future earnings or consumption in some cases, contrary to theory. In addition to indicating the need for more research, this comparison suggests that, in the interim, VSL estimates should be bounded below by estimates of future income or consumption.

15 January 2019 in Journal of Benefit-Cost Analysis
Verified
Journal Article
Open access
PDF file
LRLisa Robinson
Lisa Robinson
JHJames K. Hammitt
James K. Hammitt
LOLucy O’kEeffe
Lucy O’kEeffe
The estimates used to value mortality risk reductions are a major determinant of the benefits of many public health and environmental policies. These estimates (typically expressed as the value per statistical life, VSL) describe the willingness of those affected by a policy to exchange their own income for the risk reductions they experience. While these values are relatively well studied in high-income countries, less is known about the values held by lower-income populations. We identify 26 studies conducted in the 172 countries considered low- or middle-income in any of the past 20 years; several have significant limitations. Thus there are few or no direct estimates of VSL for most such countries. Instead, analysts typically extrapolate values from wealthier countries, adjusting only for income differences. This extrapolation requires selecting a base value and an income elasticity that summarizes the rate at which VSL changes with income. Because any such approach depends on assumptions of uncertain validity, we recommend that analysts conduct a standardized sensitivity analysis to assess the extent to which their conclusions change depending on these estimates. In the longer term, more research on the value of mortality risk reductions in low- and middle-income countries is essential.

24 July 2016 in Health Policy and Planning
Verified
Journal Article
Closed access
PDF file
LRLisa Robinson
Lisa Robinson
JHJames K Hammitt
James K Hammitt
ACAngela Y Chang
Angela Y Chang
SRStephen Resch
Stephen Resch
Researchers and policymakers have long been interested in developing simple decision rules to aid in determining whether an intervention is, or is not, cost-effective. In global health, interventions that impose costs per disability-adjusted life year averted less than three and one times gross domestic product per capita are often considered cost-effective and very cost-effective, respectively. This article explores the conceptual foundation and derivation of these thresholds. Its goal is to promote understanding of how these thresholds were derived and their implications, as well as to suggest options for improvement. These thresholds are intended to reflect the monetary value of the benefits to affected individuals, based on their preferences for spending on health vs spending on other goods and services. However, the current values were not rigorously derived, which means that their application may lead to inappropriate conclusions regarding which interventions should be adopted as well as misallocation of resources across health and other investments. Improving the basis for these cost-effectiveness thresholds is of particular importance in low- and middle-income countries, given the limited resources available and the significant needs of their populations.

1 October 2011 in Annual Review of Resource Economics
Verified
Journal Article
Closed access
MCMaureen Cropper
Maureen Cropper
JHJames K. Hammitt
James K. Hammitt
LRLisa Robinson
Lisa Robinson
The value of mortality risk reduction is an important component of the benefits of environmental policies. In recent years, the number, scope, and quality of valuation studies have increased dramatically. Revealed-preference studies of wage compensation for occupational risks, on which analysts have primarily relied, have benefited from improved data and statistical methods. Stated-preference research has improved methodologically and expanded dramatically. Studies are now available for several health conditions associated with environmental causes, and researchers have explored many issues concerning the validity of the estimates. With the growing numbers of both types of studies, several meta-analyses have become available that provide insight into the results of both methods. Challenges remain, including better understanding of the persistently smaller estimates from stated-preference than from wage-differential studies and of how valuation depends on the individual's age, health status, and characteristics of the illnesses most frequently associated with environmental causes.

1 July 2007 in Review of Environmental Economics and Policy
Verified
Journal Article
Closed access
PDF file
LRLisa Robinson
Lisa Robinson
One challenging task faced by US government agencies is determining whether the benefits of their proposed regulations justify the costs. For benefits associated with reducing the risks of premature mortality, they rely on an analytic construct—the value per statistical life (VSL)—which aggregates the value of small changes in mortality risk across a large population; it is not the value of saving a particular person's life. Empirical research suggests that this value ranges from roughly $1 million to $10 million per statistical life. While federal agencies usually apply values from within this range, they vary in the exact estimates used.

16 July 2020 in Risk Analysis
Verified
Journal Article
Open access
PDF file
LRLisa Robinson
Lisa Robinson
RSRyan Sullivan
Ryan Sullivan
JSJason F. Shogren
Jason F. Shogren
Numerous analyses of the benefits and costs of COVID‐19 policies have been completed quickly as the crisis has unfolded. The results often largely depend on the approach used to value mortality risk reductions, typically expressed as the value per statistical life (VSL). Many analyses rely on a population‐average VSL estimate; some adjust VSL for life expectancy at the age of death. We explore the implications of theory and empirical studies, which suggest that the relationship between age and VSL is uncertain. We compare the effects of three approaches: (1) an invariant population‐average VSL; (2) a constant value per statistical life‐year (VSLY); and (3) a VSL that follows an inverse‐U pattern, peaking in middle age. We find that when applied to the U.S. age distribution of COVID‐19 deaths, these approaches result in average VSL estimates of $10.63 million, $4.47 million, and $8.31 million. We explore the extent to which applying these estimates alters the conclusions of frequently cited analyses of social distancing, finding that they significantly affect the findings. However, these analyses do not address other characteristics of COVID‐19 deaths that may increase or decrease the VSL estimates. Examples include the health status and income level of those affected, the size of the risk change, and the extent to which the risk is dreaded, uncertain, involuntarily incurred, and outside of one's control. The effects of these characteristics and their correlation with age are uncertain; it is unclear whether they amplify or diminish the effects of age on VSL.